Thiamine HCl 0.9% Sodium Chloride Injection USP, 500 mg per 100 mL, Single Dose Bag, Rx only, Fagron Sterile Services... — FDA record D-0023-2025

Reported terminated

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Sep 25, 2024. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product
Thiamine HCl 0.9% Sodium Chloride Injection USP, 500 mg per 100 mL, Single Dose Bag, Rx only, Fagron Sterile Services, Canton, MA NDC: 71506-079-56
Reason
cGMP violations
Classification
Class II
Recalling firm
Fresenius Kabi Compounding, LLC
Quantity
1008 bags
Agency-reported status
Terminated
Source record identifier
D-0023-2025

Open the official record

What the recall classes mean. Classification is an agency assessment, not individual medical advice.

Lot and product identifiers

Label fieldDetails supplied by the agency
Lot, code or applicabilityLot # C274-000037436, exp. date 30-Oct-24 C274-000038893, exp. date 7-Jan-25

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

Product was distributed to 125 direct accounts nationwide.

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

Dates in the source

Report date
Oct 30, 2024
Recall initiation date
Sep 25, 2024
Center classification date
Oct 21, 2024
Termination date
Aug 15, 2025

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

Related records